Tezobell (Bortezomib)

Model: Lyophilized powder for injection (in vial)

Booth No: M625

Characteristic

Strength : 3.5 mg
Dosage form : Lyophilized powder for injection
Indication : Breast Cancer, NSCLC, Prostate cancer, etc
1. The treatment of multiple myeloma patients who have received at least 1 prior therapy and have demonstrated disease progression on the last therapy
2. The treatment of patients with mantle cell lymphoma who have received at least 1 prior therapy.

Storage Condition :
When reconstituted as directed, Bortezomib may be stored at 25°C. Reconstituted Bortezomib should be administered immediately or may be stored for 8 hours under indoor lighting.
Unopened vials may be stored at below 30°C. Shelf life 24 months.

Menu

Tezobell (Bortezomib)

Characteristic

Other Products

Products you may be interested in

Highest Rated Products